Pure Biologics achieves key milestone with successful completion of Phase 0 study for PBA-0405 in cancer treatment

Pure Biologics today announced the successful completion of its Phase 0 clinical study for the novel cancer therapy, PBA-0405.

News

Inquiries

31 March

2022

Summary of 2021

Pure Biologics has published its annual report for 2021 in which it summarizes its financial results and scientific achievements.

Project PB004 – start of the in vivo studies

28 March

2022

Project PB004 – start of the in vivo studies

Pure Biologics has signed a research agreement with The Jackson Laboratory, a leading US animal research services company operating worldwide, to launch the first in vivo preclinical pilot study in the PB004 project.

Pure Biologics becomes a partner of the Warsaw Health Innovation Hub

16 February

2022

Pure Biologics becomes a partner of the Warsaw Health Innovation Hub

February 15, 2022 Pure Biologics S.A. joined as a partner to the Warsaw Health Innovation Hub initiative, being under the aegis of the Medical Research Agency.